Double-blind, randomized, placebo-controlled, pilot trial of individualized homoeopathic medicines in iron deficiency anaemia

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年7月25日

试验速览

暂无简介。

•1. Patients suffering from iron deficiency anaemia, Hb% 7-12 gm/dl and serum ferritin level <30 ng/mL, ICD-10: D50.9
•2. Both male and female patients
•3. Age 18-65 years
•4. Patients taking iron supplements will be advised to stop the supplements for 14 days, followed by re-assessment of blood markers in the next enrolment
•5. Literate patients; ability to read and write in Bengali and/or English
•6. Patients providing written informed consent

•1. Patients with haemoglobin less than 7 gm/dl (severe anaemia)
•2. Patients who are too sick for consultation
•3. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life- threatening infections affecting quality of life or any vital organ failure
•4. Pregnancy, puerperium and lactation
•5. Substance abuse and/or dependence
•6. Self-reported immune-compromised state
•7. Undergoing homoeopathic treatment for any chronic disease within last 6 months

发起方

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital